Surgical Innovations Group Plc  

(Public, LON:SUN)   Watch this stock  
Find more results for SUN
1.70
+0.08 (4.62%)
Mar 3 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 1.52 - 1.70
52 week 1.05 - 5.98
Open 1.62
Vol / Avg. 88,088.00/260,630.00
Mkt cap 8.37M*
P/E     -
Div/yield     -
EPS -0.01*
Shares 485.06M
Beta     -
Inst. own     -
*GBP

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -150.76% 9.35%
Operating margin -180.28% 10.35%
EBITD margin - 29.39%
Return on average assets -26.64% 4.11%
Return on average equity -37.87% 5.70%
Employees 93 -
CDP Score - -

Address

Clayton Wood House/6 Clayton Wood Bank
LEEDS, LS16 6QZ
United Kingdom - Map
+44-113-2307597 (Phone)
+44-113-2307598 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Surgical Innovations Group plc is a United Kingdom-based holding company. The Company is engaged in the design, development, manufacture and sale of devices for use in minimally invasive surgery (MIS) and industrial markets. The Company operates through three segments: SI Brand, OEM and Industrial. SI Brand is engaged in the research, development, manufacture and distribution of SI branded minimally invasive devices. OEM is engaged in the research, development, manufacture and distribution of minimally invasive devices for third party medical device companies through either own label or co-branding. The Industrial segment is engaged in the research, development, manufacture and sale of minimally invasive technology products for industrial application. The Company�s subsidiaries include Surgical Innovations Limited, which designs and manufactures minimally invasive devices and Haemocell Limited, which designs and manufactures autologous blood products.

Officers and directors

Chris Rea Interim Managing Director
Michael Robert Thornton Interim Chief Executive Officer, Chief Financial Officer, Company Secretary
Douglas B. Liversidge CBE Non-Executive Chairman of the Board
Michael John McMahon Non-Executive Director, Chair of the Clinical Advisory Board